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Abstract
In experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS), 
induction generates successive waves of clonally expanded CD4+, CD8+, and γ+ T cells in the 
blood and central nervous system, similar to gluten challenge studies of Celiac patients. In MS 
patients, we also observe major expansions of CD8+ T cells. In EAE, we find that most expanded 
CD4+ T cells are specific for the inducing myelin peptide MOG35–55 but in contrast, surrogate 
peptides derived from a yeast peptide-MHC display library for some of the clonally expanded 
CD8+ T cells inhibit disease by suppressing the proliferation of MOG-specific CD4+ T cells. 
These results suggest the induction of autoreactive CD4+ T cells triggers an opposing mobilization 
of regulatory CD8+ T cells.
Susceptibility to Multiple sclerosis (MS) and many other autoimmune diseases correlates 
strongly with specific major histocompatibility complex (MHC) class II alleles1–3, and 
CD4+ T cell involvement in MS and experimental autoimmune encephalomyelitis (EAE) is 
well established1,4,5. Additionally, the presence of CD8+ T and γδ+ T cells in EAE and MS 
brain lesions has also been described, but their role in the disease, if any, is not 
understood6–8. Previously, we have shown that celiac patients exposed to gluten mobilize not 
only gluten-specific CD4+ T cells in the blood, as expected, but also gut homing CD8+ and 
γδ+ T cells as well9.
Here, we asked whether the coordinated T cell response that we saw in the Celiac study9 
might also occur in EAE, and found that it does, both in the blood and in the central nervous 
system (CNS). While the expanded CD4+ T cells are largely specific for the MOG35–55 
peptide, clonally expanded CD8+ T cells were non-responsive to myelin peptides or 
proteins. To identify the target antigens, we screened six CD8+ TCRs on a class I MHC 
molecule H2-Db yeast p-MHC display library10,11 and obtained surrogate peptides (SP) for 
two of these TCRs and these SP greatly reduced severity. Further analyses show that these T 
cells represent a unique subset of regulatory CD8+ T cells which suppress MOG35–55 
specific CD4+ T cell proliferation, suggesting that the induction of autoreactive CD4+ T 
cells in EAE triggers a counteracting wave of regulatory CD8+ T cells. In newly diagnosed 
MS patients, TCR analysis showed modest CD4+ clonal expansions, very pronounced CD8+ 
T cell clonal expansions, and similar skewing towards an IL-17 phenotype in the γδ+ T 
cells. Most importantly, given the similarities described above in the dynamics of T cell 
responses in celiac disease, EAE, and MS, it seems likely that pathogenic CD4+ and γδ+ Τ 
cell responses opposed by regulatory CD8+ T cell responses may be a common phenomenon 
across autoimmune diseases.
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Results
Mobilization of three distinct T cell types following EAE induction
Here, we performed a broad survey of T cell dynamics post EAE induction5 (Fig. 1a and 
Extended Data Fig. 1a). We observed a gradual and significant increase in the frequency of 
total CD4+ T cells in the blood from day (D)0-D10 post-immunization (PI), peaking around 
D10, declining to below baseline level at D15, with an eventual recovery on D17. A similar 
drop and recovery in the frequency of total CD4+ T cells was again observed on D19 and 
D21, respectively (Fig. 1b). We also observed a similar significant increase in the frequency 
of total CD8+ and γδ+ T cells in the blood at D10 PI, and the kinetics and the magnitude of 
response among these T cells precisely matched that of CD4+ T cells (Fig. 1b). This pattern 
of synchronous behavior was also observed in the CNS (Fig. 1c).
Splenic and lymph node (LN) T cells exhibited a different pattern, with a gradual decline in 
the frequency of total CD4+, CD8+, and γδ+ T cells from D0-D7, a rise in frequency until 
D17, and another dip between D17 and D30 (Fig. 1d and 1e). Parallel to this, there was also 
corresponding changes in the frequency of effector cells (Extended Data Fig. 2a, 2c, and 2e) 
and naïve T cells PI (Extended Data Fig. 2b, 2d, and 2f).
CD4+, CD8+, and γδ+ T cells clonally expand following EAE induction
To determine whether these waves of T cells constitute a focused immune response, we 
performed single-cell paired TCR sequencing9,12 (Fig. 2a) of effector T cells (Fig. 2b and 
Supplementary Table. 1). All three types of T cells showed increased clonal expansion 
starting at D7 (Fig. 2c and Extended Data Fig. 1b-e). Among γδ+ T cells, we found that 
nearly all the clonally expanded and some non-clonal γδ+ T cells in the blood and CNS are 
enriched for natural γδ+ 17 T cells (nTγδ17)13 TCRs (Extended Data Fig. 1f and 1g).
Clonally expanded CD8+ T cells are not responsive to myelin antigens
To determine whether the expanded CD4+ T cell clones are MOG responsive, we expressed 
four of the these CD4+ TCRs (Supplementary Table. 2) in SKWαβ−/− cells and stained them 
with a MOG35–55 I-Ab peptide-MHC tetramer, which showed robust tetramer staining (Fig. 
3a-d), reinforcing the primacy of MOG specific CD4+ T cells in this disease14–17 and 
validating our strategy of sequencing activated/effector cells as a way to enrich for clonally 
expanded T cells important in an immune response.
To investigate the antigen(s) specificity of the CD8+ T cells in EAE, 58αβ−/− cells 
expressing nine of the clonally expanded and common CD8+ TCRs (EAE1-CD8 to EAE9-
CD8 (Extended Data Fig. 2g and Supplementary Table. 3) were co-cultured with bone 
marrow derived dendritic cells (BMDCs) pulsed with myelin protein derived peptide 
(Supplementary Table. 4). Surprisingly, none of the 350-myelin peptides stimulated any of 
the CD8+ TCR cell lines (Fig. 3e). Cells expressing ovalbumin specific TCR (OT-1) 
stimulated with the SIINFEKL peptide, gave a robust activation (Fig. 3e and Extended Data 
Fig. 2i) as well as anti-CD3 + anti-CD28 stimulation (Extended Data Fig. 2h). The myelin 
proteins also did not stimulate any of the CD8+ TCR cell lines, whereas OT-1 T cells were 
robustly stimulated with ovalbumin protein (Fig. 3e and Extended Data Fig. 2i and 2j) 
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suggesting that very few of the activated and clonally expanded CD8+ T cells during EAE 
are specific for myelin antigens.
Generation of a H2-Db yeast peptide-MHC library
To discover the peptide antigens for these EAE-CD8 TCRs, we designed yeast peptide-H2-
Kb and H2-Db library constructs with SIINFEKL or SSLENFRAYV peptides10,11,18,19 
(Extended Data Fig. 3a and 3b). Initial constructs did not bind to their cognate TCRs, 
indicating incorrect folding. To rescue proper folding, we subjected both the H2-Kb and H2-
Db full length construct to error-prone mutagenesis10. While this was unsuccessful with H2-
Kb, we found that a single H2-Db mutation restored TCR recognition (Extended Data Fig. 3c 
and 3e-g) and thus we generated two different peptide libraries with this mutation and 
mutagenized the 9 and 10 aa inserts with limited diversity at the MHC anchor positions 
(Extended Data Fig. 3a-d). The estimated diversity for both peptide libraries were 5X108.
Class I peptides Immunization protects mice from EAE
Six of the clonally expanded EAE-CD8 TCRs (Supplementary Table. 3) were used to screen 
the H2-Db yeast-pMHC libraries10,11. After four rounds of selection, the flu specific control 
(6218), EAE6, and EAE7 TCRs showed robust tetramer staining (Fig. 4a-c and 
Supplementary Table. 5). While we obtained a perfect match with the flu TCR and its known 
peptide (Fig. 4d), we did not find any matches in the mouse genome for the two EAE TCR 
peptides (Fig. 4e and 4f). Nevertheless, they can still serve as important surrogates when 
complexed with H2-Db.
To characterize these CD8 SP, Jurkat αβ−/− cells expressing 6218, EAE6, and EAE7-CD8 
TCRs were stained with corresponding yeast library enriched pMHC tetramers 
(SSLENFRAYV for 6218, ASRSNRYFWL and SMRPNHFFFL for EAE6-CD8, and 
YQPGNWEYI for EAE7-CD8), which showed robust staining (Extended Data Fig. 4a). 
Moreover, upon analyzing the enriched peptide sequences for EAE7-CD8 TCR, we noticed 
that the 36th enriched peptide (HDRVNWEYI) was very similar to the top enriched 
YQPGNWEYI peptide. EAE7-CD8 TCR cell line was stained with HDRVNWEYI H2-Db 
pMHC tetramers which showed robust tetramer staining (Extended Data Fig. 4a).
To determine the immune response elicited by these SP, we immunized mice either with 
adjuvant, MOG35–55, all four peptides together [YQPGNWEYI (YQP), HDRVNWEYI 
(HDR), ASRSNRYFWL (ASR), and SMRPNHFFFL (SMRP) – SP immunization], or 
MOG35–55 with all four peptides together (MOG + SP immunization). 10D PI, spleen and 
LN CD8+ T cells were enriched separately with SP-H2-Db tetramers (Extended Data Fig. 
4b). We also tetramer enriched MOG specific CD4+ T cells from mice immunized with 
MOG35–55. EAE immunization elicited MOG specific CD4+ T cells20 (Fig. 5a and 5c). We 
detected very few SP specific CD8+ T cells in WT, MOG35–55, or adjuvant immunized mice. 
However, with MOG + SP immunization, the frequency of CD8+ T cells specific for ASR, 
HDR, and SMRP increased (Fig. 5b and 5d). In comparison to WT mice, SP immunization, 
elicited a higher frequency of CD8+ T cells specific for HDR and SMRP, with no change in 
the number of ASR and YQP specific CD8+ T cells (Fig. 5b and 5d) and these cells 
exhibited activated and effecter phenotypes after immunization (Extended Data Fig. 4b-d). 
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Thus, these SP’s identify a pre-existing pool of specific CD8+ T cells in mice that can be 
activated, and some proliferate upon immunization.
To test the effect of these peptides on EAE, we induced EAE with or without the SPs. While 
the MOG immunization induced severe disease in 100% of the mice, the addition of the SP 
with MOG resulted in much less severe or no disease, with only a 30% incidence of very 
mild disease, with most mice exhibiting no symptoms at all (Fig. 5e and Supplementary 
Table. 6). Immunization of mice with MOG35–55 + a flu peptide resulted in no significant 
difference on EAE severity (Extended Data Fig. 4e). We tested the prophylactic or 
therapeutic effect of these peptides in EAE by immunizing the mice with SP a week prior or 
after MOG immunization (MOG and SP Challenge, respectively) and with both of these 
challenges, mice had less severe disease (Fig. 5f and 5g and Supplementary Table. 7). 
Overall, MOG + SP immunization significantly ameliorates EAE.
Class I peptides immunization suppresses MOG35–55 specific CD4 T cells
To investigate whether this decreased severity with the SP addition was directly affecting 
MOG specific CD4+ T cells, we analyzed the frequency of MOG35–55 specific CD4+ T cells 
in spleen and LN with a MOG35–55 I-Ab tetramer upon MOG or MOG + SP immunizations. 
As expected, MOG immunization resulted in an increase in the number of MOG35–55 CD4+ 
T cells (Fig. 6a and 6b and Extended Data Fig. 5a). Interestingly, there was a significant 
reduction in the frequency of these T cells among MOG + SP immunized mice (Fig. 6a and 
Extended data Fig. 5b and 5c). To examine this in vitro, we CellTrace™ Violet Dye (CTV) 
labelled CD4+ T cells from MOG immunized mice and that were co-cultured and stimulated 
with MOG35–55 in the presence or absence of CD8+ T cells derived from MOG + SP or SP 
immunized mice and the magnitude of CD4+ T cell proliferation was quantified. CD4+ T 
cells proliferated robustly to MOG35–55 in the absence of CD8+ T cells (Fig. 6c). However, 
the addition of CD8+ T cells from either MOG + SP or SP immunized mice resulted in a 
significant decline in the proliferative capacity of CD4+ T cells (Fig. 6d) indicating that 
either condition elicits CD8+ T cells which actively suppresses MOG35–55 specific CD4+ T 
cells proliferation. However, CD8+ T cells from either the WT, MOG + flu peptide 
immunized or from the adjuvant immunized mice did not suppress MOG35–55 stimulated 
CD4+ T cells (Extended data Fig. 6a-e). Furthermore, MOG + SP induced CD8+ T cells did 
not suppress the proliferative capacity of ovalbumin specific CD4+ T cells, suggesting that 
suppression is antigen specific (Extended data Fig. 6h).
Class I peptides immunization elicits a unique subset of regulatory CD8+ T cells
Interestingly, we find that MOG + SP and SP immunization elicit significantly higher 
frequency of CD8+ T cells and individual SP specific CD8+ T cells expressing CD44, 
CD122, and Ly49, as shown by Cantor and colleagues to be the markers for Qa-1b restricted 
regulatory CD8+ T cells21 (Fig. 6e and Extended Data Fig. 5d-h). We find that the EAE 
CD8-TCRs described here are not Qa-1b restricted, as we did not see any effect of the anti-
Qa-1b antibody22 on the CD8 suppression of MOG specific CD4+ T cells (Extended Data 
Fig. 6g). To determine whether CD8+ T cells with this phenotype can actively suppress 
MOG35–55 specific CD4+ T cells in vitro, CD4+ T cells from MOG immunized were co-
cultured either with total CD8+ T cells or purified CD8+CD44+CD122+Ly49+(Ly49+) or 
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CD8+CD44+CD122+Ly49−(Ly49−) T cells from MOG + SP immunized mice. We found that 
total CD8+ T cells as well as Ly49+CD8+ T cells from MOG + SP immunized mice 
suppressed MOG35–55 specific CD4+ T cell proliferation (Fig. 6f-g, and 6i) whereas no 
suppression is observed with Ly49− T cells (Fig. 6f and 6h). Additionally, we adoptively 
transferred Ly49+ and Ly49− cells into mice prior to EAE induction23 and found Ly49+ cells 
from MOG + SP immunized mice significantly reduced EAE with no effect upon 
transferring Ly49− cells (Extended data Fig. 6i). This suggests that not only Ly49+ cells can 
suppress CD4+ T cells in vitro but that they also suppress EAE in vivo.
We also tested the effects of SP on another autoimmune disease model, Experimental 
autoimmune uveitis (EAU). We induced EAU in C57BL6/J24 and compared EAU pathology 
to mice immunized with human interphotoreceptor binding protein (IRBP) + SP. IRBP 
immunization mice produced a mild inflammatory response in 40% of the mice (Extended 
Data Fig. 6j and 6k). Interestingly, IRBP + SP immunization resulted in a more severe 
inflammatory response in a much greater fraction of the mice (80%) (Extended Data Fig. 
6l). We also performed in vitro suppression assays in which we found that CD4+ T cells 
robustly proliferated in the absence of CD8+ T cells from IRBP + SP immunized mice 
(Extended Data Fig. 3m) and neither Ly49+ or the Ly49− CD8+ T cells from IRBP + SP 
mice were able to suppress the proliferation of IRBP specific CD4+ T cells (Extended Data 
Fig. 6n and 6o). Thus, the EAE SPs seem specific to that disease.
It has been shown that Qa-1b restricted regulatory cells mediate their effect through 
Perforin23. To test this possible mechanism in our system, we co-cultured CD4+ T cells from 
MOG35–55 immunized mice with CD8+ T cells derived from Perforin knockout mice 
immunized with MOG + SP and found that the this completely abolished their suppressive 
capacity (Extended Data Fig. 6f). Additionally, we performed RNA-seq analysis of SP 
specific CD8+ T cells from MOG and MOG + SP immunized mice as well as CD8+ (Ly49+ 
versus Ly49−) T cells from MOG + SP immunized mice. Gene ontology enrichment analysis 
of the differentially expressed genes between Ly49+ vs Ly49− showed genes involved in 
various T cell functions (Extended data Fig. 7a and 7b and Supplementary Table. 8). 
Interestingly, SP specific CD8+ T cells showed a marked upregulation of Ly49 genes, most 
of which are inhibitory, in addition to NK cell receptor genes, and genes associated with 
CD8+ T cell effector and memory functions (Fig. 6j). In addition, Ly49+ and SP specific 
CD8+ T cells also express many genes associated with regulatory CD4+ T cells25 (Extended 
Data Fig. 7c). Overall, our results strongly suggest that the SP immunization elicits CD8+ T 
cells with a regulatory phenotype which suppresses pathogenic MOG35–55 specific CD4+ T 
cells through cytotoxicity, ultimately resulting in resistance to EAE.
Parallels with Multiple Sclerosis
To determine are there any similarities with MS, we first determined the frequency of CD4+, 
CD8+, and γδ+ T cells directly in recently diagnosed MS patients and found no differences 
in the frequency of total T cells in the peripheral blood compared to healthy controls (HC) 
(Extended Data Fig. 8a-c). However, when we performed single cell TCR sequencing of 
activated brain homing (CD38+HLA-DR+CD49d+CD29+) CD4+, CD8+, and γδ+ T cells 
from PBMCs of newly diagnosed MS patients and HCs (Supplementary Table. 9), we 
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observed a massive oligoclonal expansion of CD8+ T cells in MS patients compared to HCs 
(Extended Data Fig. 8d and 8e), which is similar to that observed in EAE and celiac 
disease9. We also observed only a few oligoclonal expansions of CD4+ T cells in MS 
patients (Extended Data Fig. 9a and 9b).
Additionally, we find that γδ+ T cells are clonally expanded in MS patients and also in HCs 
(Extended data Fig. 10a and 10b). The oligoclonal expansions of γδ+ T cells in MS has been 
noted before26,27,28. Unlike mouse nTγδ17 cells, the differentiation of human γδ17 T cells 
is poorly understood and it has been shown that in vitro activation of Vγ9+δ2+ T cells 
induces ROR-related orphan receptor gamma (RORγ) expression and IL-17 production29,30. 
In fact, we detected a significant increase in the frequency of RORC transcript positive γδ+ 
T cells in MS patients (Extended data Fig. 10c). Therefore, it is possible that in chronic 
autoinflammatory setting like MS some of these expanded γδ+ T cells potentially produce 
IL-17 and contribute to disease pathogenesis as like EAE.
Discussion
We show here that the simultaneous mobilization of oligoclonal T cells, seen earlier in celiac 
patients9, has a parallel not only in EAE, but also to some extent in newly diagnosed MS 
patients. When we systematically characterized each of these cell types, we found two of the 
three are likely pathogenic: specifically, the γδ+ T cells that dominate the response are well 
known to be producers of a pro-inflammatory cytokine, IL-1713,31,32,33, while the CD4+ T 
cell response is predominantly MOG-specific14,15,17, a key driver of EAE pathology4. In 
contrast to these two cell types, the clonally expanded CD8+ T cells exhibit a regulatory 
function. These T cells have a distinct phenotype and extend observations centered on Qa-1b 
restricted regulatory CD8+ T cells21,23,34–37,36,43,44 to include peptides presented by the 
classical class I MHC molecule H2-Db.
More importantly, our study shows the value of studying T cell specificity and activity from 
“the ground up”, that is, identifying the T cells that are most active in a given response by 
single cell paired TCR sequencing, using both activation markers and clonal expansion as 
key indicators, and ligand identification either with a yeast display library or candidate 
antigens and reporter cells transfected with the relevant TCR pairs14. This is in contrast to 
traditional methods38 which typically involve knowing (or guessing) what the relevant 
antigens are.
In summary, the work presented here indicates that there is a subset of CD8+ T cells that can 
suppress pathogenic CD4+ T cells in mice and likely in humans, and that this gives rise to 
the dynamic co-mobilization of T cells upon disease induction that we see in both Celiac 
disease and EAE. Determining the ligands for these regulatory CD8+ T cells in autoimmune 
diseases could thus be of significant value therapeutically.
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Methods
Laboratory animals
Female C57BL/6J mice (referred to as either B6 or WT) and female Perforin knockout mice 
(Stock No: 002407) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). 
The experimental procedures used in this study were approved by the Animal Care and Use 
Committee of the Stanford University.
Human Samples
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy blood donations 
from Stanford Blood Center. Healthy human subjects were male and female, ages 22–47 yrs. 
PBMCs from Multiple sclerosis patients were obtained from the Multiple Sclerosis Center at 
the University of California, San Francisco (UCSF). The committee on Human Research at 
UCSF approved the protocol, and informed consent was obtained from all participants. 
Detailed information on the patient population included in the study is provided as 
Supplementary Table. 7.
Generation of soluble TCRs
Soluble TCRs were generated as previously described10. TCR variable mouse-constant 
human (VmCh) chimeras containing an engineered C domain disulfide were cloned into the 
pAcGP67a insect expression vector (BD Biosciences, 554756) encoding either a C-terminal 
acidic GCN4-zipper-Biotin acceptor peptide (BAP)-6xHis tag (for α chain) or a C-terminal 
basic GCN4 zipper-6xHis tag (for β chain)39. Each chain also encoded a 3C protease site 
between the C terminus of the TCR ectodomains and the GCN4 zippers to allow for 
cleavage of zippers. Baculoviruses for each TCR construct were created in SF9 cells via co-
transfection of BD Baculogold linearized baculovirus DNA (BD Biosciences, 554739) with 
Cellfectin II (Life Technologies, 10362–100). TCRα and β chain viruses were coinfected in 
a small volume (2 ml) of High Five cells in various ratios to find a ratio to ensure 1:1 α:β 
stoichiometry. To prepare soluble TCRs, 1L of High Five cells were infected with the 
appropriate ratio of TCRα and TCRβ viruses for 48 hr at 28C. Collected culture media were 
conditioned with 100 mM Tris-HCl (pH 8.0), 1 mM NiCl2, 5 mM CaCl2, and the subsequent 
precipitation was cleared via centrifugation. The media were then incubated with Ni-NTA 
resin (QIAGEN 30250) at room temperature for 3 hr and eluted in 1×HBS+200 mM 
imidazole (pH 7.2). TCRs were then site-specifically biotinylated by adding recombinant 
BirA ligase, 100 μM biotin, 50 mM Bicine pH 8.3, 10 mM ATP, and 10 mM Magnesium 
Acetate and incubating 4C overnight. The reaction was then purified via size-exclusion 
chromatography using an AKTAPurifier (GE Healthcare) on a Superdex 200 column (GE 
Healthcare). Peak fractions were pooled and then tested for biotinylation using an SDS-
PAGE gel shift assay. Proteins were typically 100% biotinylated.
Generation of a mouse yeast displayed H2-Db peptide library, Tag enrichment, Staining, 
and selection
The single chain trimer (SCT) H2-Db yeast constructs were synthesized as N-terminal 
fusions to the yeast surface protein Aga2p. Full length SCT H2-Db constructs were cloned 
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into the vector pYAL. These constructs contained an Aga2p leader sequence followed by the 
9–10MER peptide sequence, a Gly-Ser (GGGGS)3 linker, the murine β2-microglobulin 
(β2M) sequence, a second glycine linker (GGGGS)4, the mouse H2-Db heavy chain 
sequence, either a Myc or HA epitope tag, a third glycine linker (GGGGS)3, and the Aga2 
protein. SCT H2-Db MHC constructs were then electroporated into EBY-100 yeast as 
previously described40,41 and induced for expression in SGCAA pH 4.5 media at 20C 24–72 
hr until maximum epitope tag staining was observed (typically 40%–70% of total 
population). The full length H2-Db yeast construct was mutagenized as described 
previously40. Briefly, the construct was mutagenized via error prone PCR (Genemorph II kit, 
Agilent 200550), with final error rate of ~ 4–5 nucleotide substitutions per kbp as judged by 
ligating error prone constructs into the pYAL vector and sequencing the clones. Yeast 
libraries were created by electroporation of competent EBY-100 cells via homologous 
recombination of linearized pYAL-cMyc/HA vector. Final libraries contained approximately 
5×108 yeast transformants. Peptide libraries were created in the same manner as the error 
prone libraries, except pMHC constructs were instead randomized along the peptide by 
using mutagenic primers allowing all 20 amino acids via an NNK codon as previously 
described. The libraries allowed only limited diversity at the known MHC anchor residues to 
maximize the number of correctly folded and displayed pMHC clones in the library. For H2-
Db, P5 and P9 anchors were limited to Asn (N) and Met/Ile/Leu (M/I/L) using AAC and 
MTS codons, respectively. The resulting PCR product was used as template for a second 
PCR reaction in which 50 nucleotides of sequence homologous to the vector was added to 
both ends of the PCR product. Then, 50 ug of this second PCR product and ~10 ug of 
linearized vector were purified and used for electroporating yeast to create each library. 
Before selecting on the H2-Db 9MER and 10MER pMHC libraries, each library was 
enriched for its respective epitope tag to maximize the percentage of yeast in the initial pool 
with correctly folded and displayed pMHC molecules presented on their surface. To achieve 
this, each of the libraries was induced separately in 500mL SGCAA at 20C for 24–72 hr 
with a starting density of 1×107 cells/mL. When maximum epitope tag staining was 
observed, approximately 1.4×109 induced yeast cells were washed once in PBS + 0.5% BSA 
and 1mM EDTA (PBE buffer) and resuspended in 5mL PBE with 200 uL of Miltenyi 
streptavidin microbeads (Miltenyi, 130–048-101). The cell and bead mixture were incubated 
at 4C with rotation for 1 hr, washed again in PBE, resuspended in 5mL PBE, and passed 
through a cell strainer onto a prewetted MACS LD column (Miltenyi 130–042-901). After 
allowing the column to fully empty, it was washed twice with 2 mL PBE, and the flow-
through was collected. Cells were isolated from the flow-through by centrifugation and 
resuspended in 5 mL PBE with 80 uL of anti-cMyc AlexaFluor647 or anti-HA 
AlexFluor647 antibody (Cell signaling, 2233 and 3444), respectively incubated at 4C with 
rotation for one hour. The cells were washed and resuspended in 5 ml PBE, with 220 uL of 
Miltenyi anti-AlexaFluor647 microbeads added (Miltenyi, 130–091-395). This mixture was 
incubated at 4C for 30 minutes with rotation and protected from light. The cells were then 
washed, resuspended in 6mL PBE, and split evenly between two pre-wet MACS LS 
columns (Miltenyi, 130–042-401). After allowing the columns to fully empty, each column 
was washed two times with 3 mL of PBE, and the flow-through was set aside. The cells 
were eluted from the columns with 5mL PBE per column. A small fraction of the eluate (5–
20 uL) was reserved to compare AlexaFluor647 staining to that of the flow-through for a 
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quantification of tag enrichment. The rest of the eluted cells were pooled, collected by 
centrifugation, resuspended in a total of 40 mL SDCAA media, and the cell density was 
measured by spectrophotometer at 600 nm. The cell density was then adjusted to an OD of 1 
or less with the addition of SDCAA, and the yeast were cultured at 30C overnight. The cells 
were the passaged for another round of overnight growth in SDCAA. For induction of the 
tag enriched library for the first round of selection, 10 times the number of cells retrieved in 
the eluate were taken for culture at 20C in 500 mL of SGCAA. To stain pMHC with TCR 
tetramers, biotinylated TCR was incubated with streptavidin coupled to AlexaFluor647, 
AlexaFluor488, or Phycoerythrin in a 5:1 ratio for 5 min on ice to ensure complete tetramer 
formation. Yeast cells were then stained with 250 nM tetramer + anti-Myc-AlexaFluor488 or 
anti-HA-AlexaFluor488 antibodies (Cell Signaling, 2279 or 2350, respectively) for 3 hr on 
ice and washed twice with ice cold PBE buffer before analysis via flow cytometry (Accuri 
C6 flow cytometer). All the yeast selections and sequencing of yeast libraries were done as 
previously described10,11.
List of primers used for H2-Db Libraries
For generating H2-Db error-prone libraries:
Forward primer: 
−5’TGCAGTTACTTCGCTGTTTTTCAATATTTTCTGTTATTGCTAGCGT 
TTTAGCAAGCAGCCTGGAGAACTTCAGAGCCTACGTGG-3’
Reverse: 5’-GAACAAAAGCTTATCTCCGAAGAAGACTTG-3’.
For the random H2-Db library:
Forward primer for 9MER HA library (initial randomization PCR): 5’-
TCAATATTTTCTGTT 
ATTGCTAGCGTTTTAGCANNKNNKNNKNNKAACNNKNNKNNKMTSGGTGGAGG
AGGTTCTG-3’.
Reverse primer for 9MER HA library (initial randomization PCR): 5’-
TCCACCACCACCAGC GTAGTCTGGAACGTCGTATGGGTAGGATCCCTCCCA-3’.
To add overlap for homologous recombination with linearized pYAL vector:
Forward primer:5’-
ATTTTCAATTAAGATGCAGTTACTTCGCTGTTTTTCAATATTTTCTG 
TTATTGCTAGCGTTTTAGCA-3’.
Reverse primer:5’-TCCACCACCACCAGCGTAGTCTGGAACGTCGTATG 
GGTAGGATCC CTCCCA-3’.
Class I and Class II peptide monomer production, tetramerization, and tetramer 
enrichment
Peptide-I-Ab monomer production: The peptide-I-Ab monomer was generated as previously 
described20,42. Briefly, the extracellular portion of I-Ab α chain was linked to acidic zipper 
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on the C-terminus, followed by AviTag (GLNDIFEAQKIEWHE) and 6X Histidine tag. The 
peptides-myelin oligodendrocyte glycoprotein (MOG) 38–48 (GWYRSPFSRVV) or 
ovalbumin (OVA) 327–337 (VHAAHAEINEA) were tethered to the N-terminus of I-Ab β 
chain, followed by basic zipper and 6X Histidine tag. The “disulfide trap” is introduced 
through the oxidation of the cysteine at p+2 position and the cysteine at position 72 of I-Ab 
α chain mutated from valine to ensure the proper peptide binding register20,43. The α chain 
and the peptide-β chain were cloned separately into the pAcGP67A vectors by Gibson 
Assembly (New England Biosciences, E2611S). Baculoviruses for each construct were 
created in SF9 cells via co-transfection of BD baculogold linearized baculovirus DNA (BD 
Biosciences, 554739) with Cellfectin II (Life Technologies, 10362–100). The α and β chain 
viruses were coinfected in a small volume (2 ml) of High Five cells in various ratios to find a 
ratio to ensure 1:1 α:β stoichiometry. To prepare soluble monomers, 1L of High Five cells 
were infected with the appropriate ratio of α and β viruses for 48 hr at 28C. Collected 
culture media was conditioned with 100 mM Tris-HCl (pH 8.0), 1 mM NiCl2, 5 mM CaCl2 
and the subsequent precipitation was cleared via centrifugation. The media is then incubated 
with Ni-NTA resin (QIAGEN, 30250) at room temperature for 3 hr and eluted in 1×HBS
+200 mM imidazole (pH 7.2). TCRs were then site-specifically biotinylated by adding 
recombinant BirA ligase, 100 μM biotin, 50 mM Bicine pH 8.3, 10 mM ATP, and 10 mM 
Magnesium Acetate and incubating 4C overnight. The reaction was then purified via size-
exclusion chromatography using an AKTAPurifier (GE Healthcare) on a Superdex 200 
column (GE Healthcare). Peak fractions were pooled and then tested for biotinylation using 
an SDS-PAGE gel shift assay. Proteins were typically 100% biotinylated. Peptide-H2-Db 
monomer production: The peptide-H2-Db monomers were refolded with the appropriate 
peptide and human β2-microglobulin as previously described44. Briefly, H2-Db and human 
β2-microglobulin were separately expressed in BL21DE3 (ThermoFisher, C600003) in the 
form of inclusion bodies. In the H2-Db construct, H2-Db α chain was linked to AviTag and 
6X Histidine tag. The refolding was carried out using rapid dilution. Following biotinylation 
by BirA, protein was purified by size-exclusion chromatography (Superdex 200 10/300 GL) 
and stored in −80C. For YQPGNWEYI (YQP), HDRVNWEYI (HDR), ASRSNRYFWL 
(ASR) and SMRPNHFFFL (SMRP), we individually refolded the monomers and purified 
them. For peptide-H2-Db monomer of 6218 flu peptides (QGLSNMRVRL, 
VGLENMRVRL, VSLRNMRSYL and SSLENFRAYV), we refolded H2-Db with a photo-
cleavable peptide (FAPGNY-Anp-AL) and exchanged the target peptides into H2-Db upon 
UV cleavage of FAPGNY-Anp-AL45. Peptide-MHC tetramer formation: All tetramers were 
freshly prepared as previously described44. Briefly, for tetramerization, the amount of 
fluorophore-conjugated streptavidin and pMHC monomer were mixed with 4:1 molar ratio. 
One fifth amount of the fluorophore-conjugated streptavidin was added to the monomer 
solution every 10 minutes in room temperature. Enrichment of tetramer-positive T cells in 
mice and cell lines: Single cell suspensions of spleen and LN cells were prepared from 
unimmunized or immunized mice, resuspended in 200 μL FACS buffer (Ca2+/Mg2+-free 
sterile PBS with 0.5 % BSA, 0.5 mM EDTA) with Fc block (1:100) and 10 μM biotin. 
Following tetramer concentrations were used for staining cells: I-Ab-MOG38–48 tetramer (15 
nM), I-Ab-OVA327–337 tetramer (15 nM), H2-Db-ASR tetramer (25 nM), H2-Db-SMRP 
tetramer (10 nM), H2-Db-YQP tetramer (25 nM) and H2-Db-HDR tetramer (25 nM). The 
cells were tetramer stained for an hour at room temperature and washed with FACS buffer. 
Saligrama et al. Page 11
Nature. Author manuscript; available in PMC 2020 April 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
For I-Ab-MOG38–48 and I-Ab-OVA327–337 tetramers, the enrichment of tetramer-positive 
cells was done using the EasySep™ PE Positive Selection Kit (STEMCELL Technologies, 
18557). If the cells were stained with both I-Ab tetramers and H2-Db tetramers, the 
enrichment of tetramer-positive cells were done using anti-PE MicroBeads (Miltenyi Biotec, 
130–048-801) and anti-His MicroBeads (Miltenyi Biotec, 130–094-258) according to 
manufacturer instructions. Following tetramer enrichment, cells were surface stained with an 
antibody cocktail for 20 minutes at 4C. Stained cells were washed using FACS buffer and 
analyzed on LSR II (Becton Dickinson) or single cell sorted/bulk sorted on FACS Aria 
Fusion SORP (Becton Dickinson). Lentivirally transduced Jurkat TCR cell lines were 
stained with tetramers at 20 nM concentration in FACS buffer with 10 μM biotin at room 
temperate for 1 hr and followed by surface staining with appropriate antibodies for 20 
minutes 4C. Following surface staining the cells were washed with FACS buffer and 
analyzed on LSR II (Becton Dickinson).
Single cell mouse and human TCR sequencing and data analysis
All human TCR primers used were previously published12. All mouse TCR primer 
sequences are provided in Supplementary Table. 1. TCR sequencing was done according to 
previously established protocols9,12.
Induction and evaluation of EAE
EAE was actively induced in C57BL/6J mice according to previously established protocol. 
Briefly, for the induction of EAE mice were injected subcutaneously in the posterior right 
and left flank with an emulsion containing 200 μg of MOG35–55 or CD8 specific SP derived 
from yeast library ASRSNRYFWL, SMRPNHFFFL YQPGNWEYI, and HDRVNWEYI, 
and an equal volume of complete Freund’s adjuvant (CFA; Sigma-Aldrich, F5881) 
supplemented with 200 μg of Mycobacterium tuberculosis H37Ra (Difco Laboratories, 
231141). On the day of immunization and 2 days post-immunization, each mouse received 
200 ng of PTX (List Biological Laboratories, 180) by intraperitoneal injection. Mice were 
scored daily for clinical signs of EAE beginning on day 5 after injection as follows: 0, no 
clinical expression of disease; 1, flaccid tail without hind-limb weakness; 2, hind limb 
weakness; 3, complete hind-limb paralysis and floppy tail; 4, hind-limb paralysis 
accompanied by a floppy tail and urinary or fecal incontinence; and 5, moribund. Clinical 
quantitative trait variables were assessed as described previously46.
CNS-infiltrating mononuclear cell isolation
CNS infiltrating cells were isolated according to previously established protocol46. Briefly, 
at different days post-immunization, animals were perfused with saline, and brains and 
spinal cords were removed. A single-cell suspension was obtained and passed through a 70-
μm strainer. Mononuclear cells were obtained by Percoll gradient (37%/70%) centrifugation 
and collected from the interphase. Cells were washed, labeled with antibody conjugated to 
fluorochrome dyes, and analyzed by flow cytometry.
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Expression of TCRs, H2-Db, and Qa-1b by lentiviral transduction
TCRα, β, H2-Db, and β2M constructs were cloned into a lentiviral construct. For TCR 
expression, alpha and beta TCR lentiviral constructs were transfected into 293X cells 
separately. The virus was harvested after 72 hr of transfection and transduced into Jurkat αβ
−/−
 or SKW αβ−/− cells. SKW or Jurkat cells were enriched for highest expression of 
TCRαβ by using a Miltenyi anti-APC selection (Miltenyi 130–090-855). Similar strategy 
was used for the expression of H2-Db and β2M, except that T2 cells were used for 
transduction and expression.
T cell stimulation assays
T cell stimulation assays were performed as previously described11. All the T cell peptide 
stimulation experiments were done in 96 well round bottom plates with a 200 ul total 
volume. T2, K562 cells or BMDCs were pulsed with 10–100ug of the peptides for 45 
minutes, washed once and plated (10, 000 cells/well). Cell lines expressing TCRs (100, 000 
cells/well) were co-cultured with APCs for 18 hr. At the end of stimulation, cells were 
harvested, washed, and stained with TCRβ, human CD3, and CD69 and analyzed on LSR II 
(Becton Dickinson) for activation.
In vitro proliferation/suppression assay
Spleen and LN cells were harvested from WT or immunized mice. Single cell suspensions 
were prepared, and RBCs were lysed using Ack lysis buffer (ThermoFisher scientific 
A1049201). Total CD4+ (Miltenyi 130–049-201) and CD8+ (Miltenyi 130–049-401) T cells 
were positively purified using Miltenyi kits following established manufacturer protocol 
followed by FACS sorting. Similarly, antigen presenting cells were isolated using Miltenyi 
Pan Dendritic Cell (DC) Isolation Kit (Miltenyi 130–100-875). Post CD4+ T cell 
enrichment, cells were counted and labelled with CellTrace™ Violet Dye (ThermoFisher 
scientific C34557) according to manufacturer instructions. In vitro proliferation/suppression 
assays were set up according to previously published protocol47. Briefly, labelled CD4+ T 
cells were co-cultured either with CD8+ T cells (1:1 ratio, 0.25X106 cells/well) or without 
CD8+ T cells in the presence of pan DC’s (0.75X106 cells/well). In some of the suppression 
experiments cells were pre-included with 10ug/ml of anti-Qa-1b neutralizing antibody 
(6A8.6F10.1A16, BD Biosciences)22,48. Cells were cultured in a total volume of 200 ul in a 
96-well round bottom plate. The CD4+ T cells were stimulated with either MOG35–55 or not. 
On day 7, the cells were washed and stained with surface antibodies and analyzed on LSR II 
(Becton Dickinson).
Adoptive transfer
EAE was actively induced in C57BL/6J mice were actively immunized with an emulsion 
containing 200 μg of MOG35–55 + CD8 specific PPTs derived from yeast library 
(ASRSNRYFWL, SMRPNHFFFL YQPGNWEYI, and HDRVNWEYI), and an equal 
volume of complete Freund’s adjuvant (CFA; Sigma-Aldrich, F5881) supplemented with 
200 μg of Mycobacterium tuberculosis H37Ra (Difco Laboratories, 231141). On the day of 
immunization and 2 days post-immunization, each mouse received 200 ng of PTX (List 
Biological Laboratories, 180) by intraperitoneal injection. Day 10 post-immunization, spleen 
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and lymph nodes were harvested, CD8+ cells were obtained using a CD8 enrichment kit and 
sorted for CD44+CD122+Ly49+ (Ly49+) and CD44+CD122+Ly49− (Ly49−) cells23. FACS 
purified Ly49+ and Ly49− cells (8 million cells/mice) were adoptively transferred at the time 
of active MOG immunization and mice were scored daily for clinical signs of EAE 
beginning on day 5 after as described previously46.
Induction and evaluation of EAU
Experimental autoimmune uveitis (EAU) was induced in mice as described previously24. 
Briefly, mice were injected subcutaneously in the posterior right and left flank with an 
emulsion containing 300 ug of human interphotoreceptor binding protein (IRBP) peptide 1–
20 in CFA (1:1 v/v), 0.2 ug of PTX on day 0 and 0.2 ug again on day 2. Mice were 
euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-
optic nerve sections were examined by histology as previously described49.
Whole transcriptome sequencing and data analysis
Whole transcriptome sequencing was done as previously described50. T cells were bulk 
sorted directly into Trizol (Qaigen). RNA was extracted with a RNeasy Plus Micro Kit 
(Qiagen). After analysis on the 2100 Bioanalyzer, the resulting library was sequenced on the 
HiSeq 4000 platform (Illumina). For each sample in the whole transcriptome sequencing 
library, 75-base pair paired-end reads were acquired from the sequencer. Each sample 
condition was completed in triplicate, except for the WT sample for which one sample was 
generated. Read quality was determined with FastQC 0.11.4. Using TopHat v2.0.13, we 
aligned the reads to the mouse reference genome (NCBI/ assembly GRCm38). On average, 
90% of reads were aligned to the reference genome. One MOG + SP sample was removed 
from downstream analysis as an identified outlier. Differential gene expression analysis and 
read count normalization used as input for heatmaps were determined via DESeq251. TPM 
values were calculated with RSEM v1.3.052. Heatmaps were generated with the R package 
“pheatmap” 53. Gene ontology analysis plots were generated with the R package 
“enrichplot” 54.
Extended Data
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Extended Data Fig. 1. Massive clonal expansion of all T cells following EAE immunization.
C57BL/6J mice were immunized for EAE induction and on different days post-
immunization (PI) [D0 (Unimmunized), D3, D5, D7, D10, D12, D15, D17, D19, D21, D23, 
and D30], blood, draining lymph nodes (LN), spleen, and CNS infiltrating cells were 
harvested and stained with a cocktail of cell surface antibodies. (a) Stained cells were 
analyzed for total frequency of different T cell types and their activation status was 
determined with the gating strategy as shown in the figure. C57BL/6J mice were immunized 
for EAE induction and on different days post-immunization (PI) [D0 (unimmunized), D7, 
D10, D15, and D19], blood and CNS infiltrating CD4+, CD8+, and γδ+ T cells were single 
cell sorted. The cells underwent single-cell paired TCR sequencing. (n = 3 mice per group/
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time point). In total, we sequenced 1302 (CD4+), 1660 (CD8+), and 1451 (γδ+) paired TCR 
sequences. (b, c, and d) Average percent clonal expansion of CD4+, CD8+, and γδ+ T cells 
among unimmunized and immunized mice in all days and tissues combined together. Data 
are shown as mean ± SEM. (e) Percent of identical CD4+, CD8+, and γδ+ TCR sequences 
shared between blood and the CNS within each day PI. (f) Frequency of major groups 
(Group 1–4) of natural γδ+ T17 (nTγδ17) cells in blood and CNS different days and tissue 
PI. (g) Corresponding paired TCRγ and TCRδ sequences which define each major group 
(Group 1–4) of nTγδ17 cells.
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Extended Data Fig. 2. Concomitant activation of all T cells following EAE immunization and 
clonally expanded CD8 TCRs are not specific to myelin peptides or proteins.
(a, c, and e) C57BL/6J mice were immunized for EAE induction and on different days PI 
[D0 (Unimmunized) (n = 5), D3 (n = 4), D5 (n = 4), D7 (n = 4), D10 (n = 4), D12 (n = 4), 
D15 (n = 5), D17 (n = 5), D19 (n = 5), D21 (n = 5), D23 (n = 5), and D30 (n = 3)], blood, 
draining LN, and spleen cells were harvested and analyzed for total frequency of activated 
(CD44high) and (b, d, and f) naïve (CD62Lhigh) CD4+, CD8+, and γδ+ T cells in the blood, 
draining LN, and spleen. Significance of differences observed in changes in frequency of 
naïve and activated T cells between days was determined using one-way ANOVA followed 
by Dunnets post hoc multiple comparison test. Data are shown as mean ± SEM. 
Representative data from two independent experiments. *p = 0.046; **p = 0.0023; ***p = 
0.0002; ****p < 0.0001. 9 clonally expanded CD8 TCRs (EAE1-CD8 to EAE9-CD8) were 
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retrovirally transduced to express on 58αβ−/− cells. (g) Un-transduced and transduced cell 
lines were stained with fluorochrome labelled anti-TCRβ and anti-CD3 to determine the 
surface expression of TCRs. (h) Un-transduced and transduced EAE-CD8 TCR cell lines 
were stimulated with plate bound anti-CD3 and soluble anti-CD28 for 12–16 hr and surface 
stained with activation marker CD69. (i) Un-transduced 58αβ−/− or OT-1 TCR transduced 
cell lines were stimulated with BMDCs pulsed with SIINFEKL peptide or whole Ovalbumin 
(OVA) protein for 12–16 hr, washed, and stained with activation marker CD69. (j) 
Unstimulated 58αβ−/− or EAE-CD8 TCR transduced cell lines were stimulated with pool of 
peptides (PP1–7) from MOG, MBP, PLP, MAG and SIINFEKL peptide and examined for 
activation marker CD69 (CD69 expression shown in figure for EAE1-CD8 TCR). Peptides 
are of variable lengths (8–12MERs). Each peptide pool contained 50 peptides. 
Representative data from three independent experiments.
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Extended Data Fig. 3. Generation and functional validation of a H2-Db yeast peptide-MHC 
library.
(a) Schematic of the murine Class I MHC H2-Db displayed on yeast as β2m, α1, α2, and α3 
with peptide covalently linked to the MHC N-terminus. (b) Design of the peptide library 
displayed by H2-Db. Design is based on the structure of the 6218 TCR bound to H2-Db-
restricted acid polymerase peptide 224–233 (SSLENFRAYV, DbPA224) (Day E B et al., 
2011, PDB, 3PQY). (c) Mutation required for proper folding of the H2-Db displayed on 
yeast (α2-W131 to α2-G131). Mutations were derived from error prone mutagenesis. (d) 
Design for two different lengths of H2-Db libraries. For nine amino acid (9 MER) library, 
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residues from P1 to P9 were randomized, with limited diversity at MHC anchor positions P5 
(Asparagine, N) and P9 (Methionine, Isoleucine, and Leucine, M/I/L). For ten amino acid 
(10 MER) library, residues from P1 to P10 were randomized, with limited diversity at MHC 
anchor positions P5 (Asparagine, N) and P10 (Methionine, Isoleucine, and Leucine, M/I/L). 
TCR contact residues are colored pink and MHC anchor residues are colored red or blue. (e 
and g) Selection of PA224-H2-Db error prone library with 6218 soluble TCR. Increased 
cMyc expression among induced yeast peptide-H2-Db error prone library at different rounds 
(RD1-RD4) of selection and (f) 6218 soluble TCR tetramer staining on the post-RD4 error 
prone H2-Db library. Each TCR was screened on the yeast library once.
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Extended Data Fig. 4. In vitro and In vivo characterization of CD8+ T cells specific for surrogate 
peptides following EAE.
(a) EAE-CD8 TCR transduced Jurkat αβ−/− T cells were pMHC tetramer stained with 6218, 
EAE6, and EAE7-CD8 TCR specific SP (SSLENFRAYV, ASRSNRYFWL, SMRPNHFFFL 
YQPGNWEYI, and HDRVNWEYI), respectively. (b) From unimmunized (n = 4), MOG (n 
= 5), MOG + SP (n = 5), or SP immunized mice (n = 5), spleen and LN cells were harvested, 
and enriched for SP specific CD8+ T cells with pMHC tetramers. Representative flow 
cytometry gating strategy is shown for different cell surface markers and tetramer specific 
cells. (c) Representative flow cytometry data is shown for activation status (defined as 
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CD44+CD62L−) on CD8+ T cells specific for SP (ASR, HDR, SMRP, and YQP-tet+) from 
WT and different immunization groups (MOG, MOG + SP, and SP). (d) Activated/effector 
phenotype of CD8+ T cells specific for SP (ASR, HDR, SMRP, and YQP-tet+) from WT (n 
= 5) and different immunization groups [MOG (n = 3), MOG + SP (n = 4), and SP (n = 3)] 
is quantified and shown as a bar graph (n = 5 mice per group). The significance of 
differences among the frequency of activated/effector cells between different immunization 
group was determined using one-way ANOVA followed by Tukey’s post hoc multiple 
comparison test. *p = 0.0169; **p = 0.0020; ****p < 0.0001. Data are shown as mean ± 
SEM. (e) C57BL/6J mice were immunized for EAE with an emulsion containing MOG35–55 
+ CFA + PTX (n =10) and Flu peptide (SSLENFRAYV) + MOG35–55 + CFA + PTX (n 
=10). The clinical scores following immunization were recorded. Data are shown as mean ± 
SEM. Representative data from two independent experiments.
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Extended Data Fig. 5. CD8+ T cell specific surrogate peptide immunization suppresses 
MOG35–55 specific CD4+ T cells and induces CD8+ T cells with a regulatory phenotype.
C57BL/6J mice were immunized with an emulsion containing MOG35–55 + CFA + PTX (n 
= 5), or with MOG35–55 + SP + CFA + PTX (n = 5). From (a) unimmunized and (b and c) 
D10 PI mice, spleen and LN cells were isolated, stained, and enriched for MOG35–55 I-Ab 
pMHC specific CD4+ T cells and an irrelevant tetramer. Representative FACS plots for 
different groups are shown. (d-g) From unimmunized (n = 5) and D10 PI MOG (n = 5), 
MOG + SP (n = 5), and SP (n = 4) immunized mice, spleen and LN cells were harvested 
stained, and enriched for SP specific CD8+ T cells using pMHC tetramer. Representative 
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FACS dot-plots for CD8+ T cell with a regulatory phenotype (CD44+CD122+Ly49+) from 
each group is shown. (h) Each tetramer+ (ASR, HDR, SMRP, and YQP-tet+) CD8+ T cells 
were sub-gated for CD122, CD44, and Ly49 and the frequency of CD122+CD44+Ly49+ 
cells among each SP specific cells are shown among different immunization groups. The 
significance of differences among the frequency of CD122+CD44+Ly49+ cells between 
different immunization group was determined using one-way ANOVA followed by Tukey’s 
post hoc multiple comparison test. ***p = 0.0002. Data are shown as mean ± SEM. 
Representative data from two independent experiments.
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Extended Data Fig. 6. CD8+ T cells elicited upon MOG + SP immunization are specific, their 
suppression is mediated by Perforin, adoptive transfer of CD122+CD44+Ly49+ abrogates EAE, 
and SP triggers a more severe, inflammatory retinal uveitis than IRBP peptide alone.
C57BL/6J mice were immunized with an emulsion containing MOG35–55 + CFA + PTX, 
MOG35–55 + SP + CFA + PTX, or MOG35–55 + Flu peptide + CFA + PTX. Spleen and LN 
cells were harvested from D10 PI mice, enriched for either CD4+, CD8+ T cells, or antigen 
presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM 
Violet (CTV) Dye labelled CD4+ T cells from MOG immunized mice were co-cultured with 
APC from MOG immunized mice either in the (a) absence of CD8+ T cells or in the 
presence of CD8+ T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or 
(f) CD8+ T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled 
CD4+ T cells from MOG35–55 + CFA + PTX immunized mice were co-cultured with CD8+ 
T cells from MOG35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/
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ml). In addition (h) CTV labelled CD4+ T cells from OVA329–337 CFA + PTX were co-
cultured with CD8+ T cells from MOG35–55 + SP + CFA + PTX immunized mice. 7 days 
post co-culture, cells were washed and stained with surface markers and analyzed for CD4+ 
T cell proliferation (CTV Dye dilution). Representative data from two independent 
experiments. C57BL/6J mice were immunized with an emulsion containing MOG35–55 + SP 
+ CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were 
isolated, stained, enriched for CD8+ T cells with Miltenyi cell enrichment kit followed by 
FACS to CD44+CD122+Ly49+ (Ly49+) and CD44+CD122+Ly49− (Ly49−) cells. Sorted 
Ly49+ and Ly49− cells were adoptively transferred (8 million cells/animal) to C57BL/6J 
mice (n = 5 mice/group) at the time of MOG35–55 + CFA + PTX immunization. (i) The 
clinical scores following adoptive transfer of Ly49+ and Ly49− cells and MOG35–55 + SP + 
CFA + PTX immunization were recorded, and the significance of differences between 
clinical courses was calculated by regression analysis with the two-way ANOVA followed 
by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean 
± SEM. Representative data from two independent experiments. (j) In the wild-type, 
untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes 
in the vitreous. (k) After subcutaneous injection of IRBP (interphotoreceptor binding 
protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with 
activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina 
outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of 
both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated 
leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina 
photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; 
INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal 
plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced 
in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were 
enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J 
mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + 
CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, 
enriched for either CD4+, CD8+ T cells, or antigen presenting cells (APC) using Miltenyi 
cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4+ T 
cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice 
with purified (n) CD8+CD44+CD122+Ly49+[Ly49+], (o) CD8+CD44+CD122+Ly49−[Ly49−] 
or (m) without CD8+ T cells from IRBP + SP immunized mice 7 days post co-culture, cells 
were washed and stained with surface markers and analyzed for CD4+ T cell proliferation 
(CTV Dye dilution).
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Extended Data Fig. 7. Transcriptional profiling of Ly49+ Vs Ly49− cells.
C57BL/6J mice were immunized with an emulsion containing SP + CFA + PTX (n = 3). (a) 
Spleen and LN cells were harvested from D10 mice, enriched for either CD8+ T cells using 
a Miltenyi CD8+ T cell enrichment kit followed by sorting for CD122+CD44+Ly49− [Ly49−] 
and CD122+CD44+Ly49+ [Ly49+] cells and then performed bulk RNA-seq on these cells. 
(a) A heatmap of differentially expressed genes (log2(fold change) > 2 and the adjusted p 
value < 0.005) in Ly49+/Ly49− RNA-seq samples. Columns show samples. Rows and 
columns are ordered based on hierarchical clustering. Normalized gene expression values 
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are centered for each gene by subtracting the average value of all samples from each sample 
value (2–3 mice/group). (b) Gene Ontology enrichment analysis of genes differentially 
expressed (log2(fold change) > 2 and the two-tailed Benjamini Hochberg adjusted p value < 
0.005 from DESeq2) between Ly49+/Ly49− RNA-seq samples. The y-axis represents the top 
30 enriched Gene Ontologies (genes from gene ontologies highlighted in green are in 
Supplementary Data Table. 6). The x-axis value is the fraction of genes in that ontology that 
are differentially expressed. The color of the dot represents that significance of the Gene 
Ontology enrichment (one-tailed Fisher’s exact test), and the size of the dot represents the 
number of genes differentially expressed. The plot was made with the R package 
“clusterProfiler.” (c) Volcano plot representing gene expression differences between the 
Ly49+ vs Ly49− samples (3 mice/group). Each point is a gene. List of genes specifically 
expressed in CD4+ Tregs (Zemmour D et al., 2018) are colored red if they are expressed in 
both MOG + SP RNA seq samples, and green if not. The horizontal dotted line is made at 
−log10(0.05), and the two vertical dotted lines represent a fold change of log2(2). Genes 
with a negative fold change are highly expressed in Ly49+ cells.
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Extended Data Fig. 8. Major clonal expansion of CD8+ T cells in recent onset MS patients.
PBMCs from healthy controls (HC) (n = 4) and MS (n = 18) patients were stained and 
analyzed by flow cytometry to determine the frequency of T cells. Frequency of (a) CD4+, 
(b) CD8+, and (c) γδ+ T cells in T cells is shown, data are shown as mean ± SEM. Brain 
homing and activated (CD49d+CD29+HLA-DR+CD38+) CD8+ T cells were single cell 
sorted from PBMCs of (d) healthy controls (HCs) and (e) newly diagnosed MS patients. The 
cells underwent single-cell paired TCR sequencing. Pie charts depicting clonal expansion of 
CD8+ T cells among HC (n = 10) and MS (n =18) patients. The number of cells with β chain 
successfully identified is shown above its pie chart. For each TCR clone expressed by two or 
more cells (clonally expanded), the absolute number of cells expressing that clone (≥2, ≥5, 
≥10, ≥20, and ≥50) is shown with a distinct colored section.
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Extended Data Fig. 9. TCR repertoire of brain homing activated CD4+ T cells in recent onset MS 
patients.
Brain homing and activated (CD49d+CD29+HLA-DR+CD38+) CD4+ T cells were single 
cell sorted from PBMCs of (a) healthy controls (HCs) and (b) recent onset MS patients. The 
cells underwent single-cell paired TCR sequencing. Pie charts depicting clonal expansion of 
CD4+ T cells among HC (n = 10) and MS (n = 18) patients. The number of cells with β 
chain successfully identified is shown above its pie chart. For each TCR clone expressed by 
two or more cells (clonally expanded), the absolute number of cells expressing that clone 
(≥2, ≥5, ≥10, ≥20, and ≥50) is shown with a distinct colored section.
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Extended Data Fig. 10. TCR repertoire of brain homing activated γδ+ T cells in recent onset MS 
patients.
Brain homing and activated (CD49d+CD29+HLA-DR+CD38+) γδ+ T cells were single cell 
sorted from PBMCs of (a) healthy controls (HCs) and (b) recent onset MS patients. The 
cells underwent single-cell paired TCR sequencing. Pie charts depicting clonal expansion of 
γδ+ T cells among HC and MS patients. The number of cells with δ chain successfully 
identified is shown above its pie chart. For each TCR clone expressed by two or more cells 
(clonally expanded), the absolute number of cells expressing that clone (≥2, ≥5, ≥10, ≥20, 
and ≥50) is shown with a distinct colored section. From the single cell sorted γδ+ T cells, 
RAR-related orphan receptor (ROR) transcripts were amplified using gene specific primers 
and sequenced simultaneously with γ and δ chains. (c) The number of γδ+ T cells positive 
for the RORC transcript is shown among HC (n = 10) and MS (n =18) patients. Significance 
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of differences observed in the number of positive cells for RORC transcript was determined 
using paired t test. *p = 0.0301. Data are shown as mean ± SEM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Concomitant activation of all T cells following EAE immunization.
(a) C57BL/6J mice were immunized for EAE induction and at different days post-
immunization (PI) blood, CNS, spleen, and draining lymph nodes (LN) cells were harvested 
and analyzed for total frequency of T cells. (b, c, d, and e) Total frequency of CD4+, CD8+, 
and γδ+ T cells in the blood, CNS, spleen, and in the LN different days PI [(D0 
(Unimmunized) (n = 5), D3 (n = 4), D5 (n = 4), D7 (n = 4), D10 (n = 4), D12 (n = 4), D15 (n 
= 5), D17 (n = 5), D19 (n = 5), D21 (n = 5), D23 (n = 5), and D30 (n = 3))]. Significance of 
differences observed in changes in frequency of T cells between days was determined using 
one-way ANOVA followed by Dunnets post hoc multiple comparison test. Data are shown 
as mean ± SEM. Representative data from two independent experiments. *p = 0.05; **p = 
0.0097; ***p = 0.0008; ****p < 0.0001.
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Fig. 2. CD4+, CD8+, and γδ+ T cells are clonally expanded following EAE.
(a) C57BL/6J mice were immunized for EAE induction and on different days PI [(D0 
(unimmunized), D7, D10, D15, and D19)] blood and CNS infiltrating CD4+, CD8+, and γδ+ 
T cells were single cell sorted based on (b) activation markers (CD44hiCD62Llow) and their 
TCRs sequenced. Pie chart depicting clonal expansion of CD4+, CD8+, and γδ+ T cells 
different days PI in (c) blood and (d) CNS. Each pie chart is an aggregate of the number of 
TCR sequences from 3 individual mice pooled together per time point per tissue. The 
number of cells with β or both γ and δ chains successfully identified is shown above its pie 
chart. For each TCR clone expressed by two or more cells (clonally expanded), the absolute 
number of cells expressing that clone is shown with a distinct colored section. Sequencing 
data is from one experiment constituting 3 individual animal per time point.
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Fig. 3. Clonally expanded CD8 TCRs are not responsive to myelin.
(a-d) 4 clonally expanded CD4 TCRs (EAE1-CD4 to EAE4-CD4) were expressed on 
SKWαβ−/− cells and stained with MOG35–55 and OVA327 I-Ab pMHC tetramer. 9 clonally 
expanded CD8 TCRs (EAE1-CD8 to EAE9-CD8) were expressed on 58αβ−/− cells. (e) 
Cells were stimulated with pools of myelin peptides from myelin oligodendrocyte 
glycoprotein (MOG), myelin basic protein (MBP), proteolipid protein (PLP), myelin 
associated glycoprotein (MAG), SIINFEKL, myelin or ovalbumin (OVA) protein, and anti-
CD3 + anti-CD28 for 12–16 hr, and examined for activation marker CD69. Each peptide 
pool (PP)1 – PP7 comprised of variable length peptides (8–12MERs), and each PP contained 
50 peptides. (e) 58αβ−/− cells expressing OT-1 TCR were stimulated with either SIINFEKL 
peptide or OVA protein. Representative data from three independent experiments.
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Fig. 4. Clonally expanded EAE CD8 TCRs bind to novel peptides.
Tetramer staining of 9 MER and 10 MER H2-Db yeast-pMHC library with (a) 6218 TCR, 
(b) EAE6-CD8 TCR, and (c) EAE7-CD8 TCR at the end of 3rd round (RD) of selection. 
Heatmaps of amino acid preference by position for (d) 6218 (left) (e) EAE6-CD8 (center) 
and (f) EAE7-CD8 (right) TCRs after three RDs of selection. Sequences of top 7 peptides 
post RD3 selection for each TCRs shown below with its amino acid preference. MHC 
anchor residues are colored in red (P5, N) or blue (P9/10, M/I/L). Each TCR was screened 
on the yeast library once.
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Fig. 5. CD8+ T cell specific surrogate peptides immunization abrogates EAE.
From unimmunized and D10 PI mice, spleen and LN cells were harvested and enriched for 
(a) CD4+ T cells specific for I-Ab MOG35–55 or (b) CD8+ T cells specific for SP 
(ASRSNRYFWL, SMRPNHFFFL YQPGNWEYI, and HDRVNWEYI). Representative dot-
plots are shown for unimmunized and immunized mice. Representative data from two 
independent experiments. (c) Frequency of CD4+ T cells specific for MOG35–55 among WT 
(n = 4) and immunized mice (n = 5) are shown as a bar graph. Data are shown as mean ± 
SEM. (d) Frequency of SP specific CD8+ T cells among WT (n = 4) and different 
immunization groups are shown as a bar graph (n = 5 mice per group). Data are shown as 
mean ± SEM. (e) EAE clinical scores among C57BL/6J mice immunized with an emulsion 
containing MOG35–55 + CFA + PTX (n =10), or with MOG35–55 + SP + CFA + PTX (n = 
10), or SP + CFA + PTX (n =10). (f) C57BL/6J mice were immunized for EAE with an 
emulsion containing MOG35–55 + CFA + PTX (n =10) and seven days post-MOG35–55 
immunization, mice were challenged with SP + ICFA + PTX (n = 10). (g) C57BL/6J mice 
were immunized for EAE with an emulsion containing SP + CFA + PTX and seven days 
post primary immunization, mice were challenged with MOG35–55 + ICFA + PTX (n =10). 
(e-g) The clinical scores following immunization were recorded, and the significance of 
differences between clinical courses was calculated by regression analysis with the two-way 
ANOVA followed by Bonferroni post hoc multiple comparison test. Data are shown as mean 
± SEM. Representative data from two independent experiments. ** p = 0.0040, **** p < 
0.0001.
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Fig. 6. CD8+ T cell specific surrogate peptides immunization suppresses MOG35–55 specific 
CD4+ T cells.
C57BL/6J mice were immunized with an emulsion containing MOG35–55 + CFA + PTX (n 
= 5), or MOG35–55 + SP + CFA + PTX (n = 4). From (a) unimmunized (n = 4) and D10 PI 
mice (n = 5 mice/group), LN and spleen cells were harvested and enriched for MOG35–55 I-
Ab pMHC specific CD4+ T cells. FACS dot-plots from representative animal from different 
groups are shown (see extended data Fig. 8a-c for data from additional mice per group). (b) 
Frequency of MOG35–55 specific CD4+ T cells from each group are shown as a bar graph. 
Representative data from two independent experiments. Data are shown as mean ± SEM. 
Saligrama et al. Page 40
Nature. Author manuscript; available in PMC 2020 April 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
C57BL/6J mice were immunized with MOG35–55 + CFA + PTX (n = 2 mice), or with 
MOG35–55 + SP + CFA + PTX (n = 2 mice), or SP + CFA + PTX (n = 2 mice). From 
unimmunized (n = 2) and D10 PI mice, LN and spleen cells were harvested, enriched for 
either CD4+, CD8+ T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment 
kits followed by FACS. Dye labelled CD4+ T cells from MOG immunized mice were co-
cultured with APC from MOG immunized mice either in the (c) absence or (d) presence of 
CD8+ T cells from MOG and MOG + SP or SP immunized mice. 7 days post co-culture, 
cells were analyzed for proliferation. Representative data from two independent 
experiments. (e) Frequency of CD8+ T cells with a regulatory phenotype 
(CD44+CD122+Ly49+) are shown among WT (n = 4) and different immunization groups (n 
= 5 mice/group). The significance of differences among the frequency of 
CD122+CD44+Ly49+ cells between different immunization group was determined using 
one-way ANOVA followed by Tukey’s post hoc multiple comparison test. Representative 
data from two independent experiments. Data are shown as mean ± SEM. *p = 0.0382; ***p 
= 0.001. CD4+ T cells from MOG immunized were co-cultured either (f) without or with (g) 
total CD8+ T cells or (h) purified CD8+CD44+CD122+Ly49+[Ly49+] or (i) 
CD8+CD44+CD122+Ly49−[Ly49−] T cells from MOG + SP immunized mice (n = 2 mice/
group). Representative data from two independent experiments. (j) A heatmap of gene 
expression in RNA-seq samples. Genes were selected on the basis that they are differentially 
expressed (log2 (fold change) > 0.75 and the adjusted p value < 0.005) and the two-tailed 
Benjamini Hochberg adjusted p value < 0.005) as defined by DESeq2 in both Ly49+/Ly49− 
and MOG/MOG + SP comparisons. Columns show samples. Rows and columns are ordered 
based on hierarchical clustering. Normalized gene expression values are centered for each 
gene by subtracting the average value of all samples from each sample value. Representative 
data from two independent experiments.
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